Ventripoint Diagnostics Ltd. (TSXV:VPT)

Market Cap	21.22M
Revenue (ttm)	95.17K
Net Income (ttm)	-4.92M
Shares Out	163.20M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	71,025
Average Volume	102,432
Open	0.1300
Previous Close	0.1350
Day's Range	0.1300 - 0.1300
52-Week Range	0.0800 - 0.2600
Beta	0.27
RSI	42.93
Earnings Date	May 1, 2025

About Ventripoint Diagnostics

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, in...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Hugh MacNaught
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: VPT

Financial Performance

In 2024, Ventripoint Diagnostics's revenue was 95,172, an increase of 93.51% compared to the previous year's 49,183. Losses were -4.92 million, 0.98% more than in 2023.